Self-reported physical activity in people with limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease in Norway.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
13 Apr 2020
Historique:
received: 27 12 2018
accepted: 27 03 2020
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 21 1 2021
Statut: epublish

Résumé

Physical activity is associated with positive health effects, but individuals with neuromuscular disease (NMD) may experience constraints being physically active. There is a gap in the literature on the activity level of people with NMDs, and therefore we did a study to determine the physical activity level in people with Limb-Girdle muscular dystrophy (LGMD) and Charcot-Marie-Tooth disease (CMT). This study used a cross-sectional design to obtain self-reported physical activity and sitting time among individuals with LGMD and CMT who were recruited from the Norwegian registry for hereditary and congenital neuromuscular diseases. A total of 127 respondents who filled out questionnaires about either physical activity or sitting time were included in the analysis. Seventy (55.1%) had a diagnosis of CMT and 57 (44.9%) had a diagnosis of LGMD. Seventy-three (57.5%) respondents were female and 54 (42.5%) were male. Among the 108 respondents with available physical activity data, 44.4% reported being physically inactive. Among the 109 respondents with available sitting time data, the average sitting time was 8.6 h. Longer sitting time was associated with higher physical inactivity. Among people with LGMD and CMT in our study, 55.6% reported being physically active. Respondents with LGMD and CMT reported longer sitting time and less physical activity compared with healthy respondents in other studies. Further research should explore variables and measures that can promote physical activity among people with neuromuscular conditions.

Sections du résumé

BACKGROUND BACKGROUND
Physical activity is associated with positive health effects, but individuals with neuromuscular disease (NMD) may experience constraints being physically active. There is a gap in the literature on the activity level of people with NMDs, and therefore we did a study to determine the physical activity level in people with Limb-Girdle muscular dystrophy (LGMD) and Charcot-Marie-Tooth disease (CMT).
METHODS METHODS
This study used a cross-sectional design to obtain self-reported physical activity and sitting time among individuals with LGMD and CMT who were recruited from the Norwegian registry for hereditary and congenital neuromuscular diseases.
RESULTS RESULTS
A total of 127 respondents who filled out questionnaires about either physical activity or sitting time were included in the analysis. Seventy (55.1%) had a diagnosis of CMT and 57 (44.9%) had a diagnosis of LGMD. Seventy-three (57.5%) respondents were female and 54 (42.5%) were male. Among the 108 respondents with available physical activity data, 44.4% reported being physically inactive. Among the 109 respondents with available sitting time data, the average sitting time was 8.6 h. Longer sitting time was associated with higher physical inactivity.
CONCLUSION CONCLUSIONS
Among people with LGMD and CMT in our study, 55.6% reported being physically active. Respondents with LGMD and CMT reported longer sitting time and less physical activity compared with healthy respondents in other studies. Further research should explore variables and measures that can promote physical activity among people with neuromuscular conditions.

Identifiants

pubmed: 32284057
doi: 10.1186/s12891-020-03246-w
pii: 10.1186/s12891-020-03246-w
pmc: PMC7155285
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

235

Subventions

Organisme : Nasjonal Kompetansetjeneste for Sjeldne Diagnoser (NKSD)/Norwegian National Advisory Unit on Rare Disorders
ID : Prosjekt 43066

Références

Arch Phys Med Rehabil. 2007 Nov;88(11):1452-64
pubmed: 17964887
Scand J Med Sci Sports. 2011 Oct;21(5):730-8
pubmed: 20459465
Lancet. 2002 Feb 23;359(9307):687-95
pubmed: 11879882
Lung. 2007 Jan-Feb;185(1):1-7
pubmed: 17294338
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Disabil Rehabil. 2014;36(11):932-9
pubmed: 23957639
Lancet. 2012 Jul 21;380(9838):247-57
pubmed: 22818937
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Int J Behav Nutr Phys Act. 2009 Mar 31;6:21
pubmed: 19335883
Int J Sports Med. 1998 Jul;19(5):328-35
pubmed: 9721056
J Neuromuscul Dis. 2015;2(1):73-85
pubmed: 28198707
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
J Neuromuscul Dis. 2017;4(1):25-52
pubmed: 28269791
Med Sci Sports Exerc. 2015 Sep;47(9):1833-40
pubmed: 25628179
J Peripher Nerv Syst. 2015 Dec;20(4):347-62
pubmed: 26010435
Obes Res. 2005 Aug;13(8):1431-41
pubmed: 16129726
Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75
pubmed: 28599680
Am J Phys Med Rehabil. 2016 Nov;95(11):789-799
pubmed: 27149585
Arch Phys Med Rehabil. 2015 Feb;96(2):260-8
pubmed: 25286435
Curr Opin Neurol. 2018 Oct;31(5):610-617
pubmed: 30036194
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003904
pubmed: 15495069
Public Health Rep. 2004 Jul-Aug;119(4):418-26
pubmed: 15219799
Diabetologia. 2017 May;60(5):830-835
pubmed: 28054097
CMAJ. 2000 Aug 8;163(3):265-71
pubmed: 10951722
Disabil Rehabil. 2017 Aug;39(17):1753-1758
pubmed: 27684376
Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S108-20
pubmed: 12409816
Med Sci Sports Exerc. 2011 May;43(5):905-12
pubmed: 20881881
J Phys Act Health. 2010 Jul;7 Suppl 2:S259-64
pubmed: 20702914
Am J Prev Med. 2011 Aug;41(2):228-35
pubmed: 21767731
Public Health Nutr. 2003 May;6(3):299-305
pubmed: 12740079
Clin Cardiol. 1990 Aug;13(8):555-65
pubmed: 2204507
Acta Myol. 2015 May;34(1):3-8
pubmed: 26155063

Auteurs

Aristomo Andries (A)

Institute of Health and Society, University of Oslo, P.O. Box 1089, N-0318, Oslo, Blindern, Norway. aristomo.andries@medisin.uio.no.

Marleen R van Walsem (MR)

Department of Neurohabilitation, Oslo University Hospital, P.O. Box 4956, N-0424, Oslo, Nydalen, Norway.
Research Centre for Habilitation and Rehabilitation Models and Services, Institute of Health and Society, University of Oslo, P.O. Box 1089, N-0318, Oslo, Blindern, Norway.

Jan C Frich (JC)

Institute of Health and Society, University of Oslo, P.O. Box 1089, N-0318, Oslo, Blindern, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH